Table 5

Univariate analysis of survival (n = 41)

Patients

Mean survival (months)

Median survival (months)

p-Value (log-rank)


Overall survival

41

4.5

3

Characteristics

Gender

0.386

Male

33

4.7

3

Female

8

3.6

2.5

Age (years)

< 50

23

4.4

3

0.893

≥ 50

18

4.6

3.5

Primary tumor

0.156

Controlled

16

5.8

3.5

Uncontrolled

25

3.7

3

Etiology

Hepatitis B

30

4.1

3

0.308

None

11

5.6

3

Child-Pugh's classification

A

27

4.9

3.5

0.364

B/C

14

3.8

3

APF (ng/ml)

< 400

15

3.4

2

0.218

≥ 400

26

5.1

3.5

CEA (ng/ml)

< 5

26

4.8

3

0.725

≥ 5

5

3.9

3

CA199 (u/ml)

0.455

< 35

22

3.9

3

≥ 35

10

5.6

3

Extracranial metastasis

Yes

33

5.2

3.5

< 0.0001

No

8

1.4

1

Lung metastasis

Yes

31

5.4

4

0.001

No

10

1.7

1.7

Bone metastasis

Yes

9

5.8

4

0.272

No

32

4.1

2.5

Brain hemorrhage

Yes

19

4.1

1.5

0.495

No

22

4.9

3.5

Interval (months)

< 12

16

3.5

3

0.272

≥ 12

25

5.1

3.5

Number of brain lesions

Single

24

4.2

3

0.572

Multiple

17

4.9

3.5

Location

Supratentorial

29

5

3

0.293

Infratentorial or combinations

12

3.4

1.5

Treatment

Surgery or WBRT and/or SRS

18

6.8

4.5

0.001

Steroid only

23

2.7

1.5

RPA class

I or II

25

6.4

6

< 0.0001

III

16

1.6

1


Jiang et al. BMC Cancer 2012 12:49   doi:10.1186/1471-2407-12-49

Open Data